BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17635800)

  • 1. Allosteric changes in the TCR/CD3 structure upon interaction with extra- or intra-cellular ligands.
    Rubin B; Knibiehler M; Gairin JE
    Scand J Immunol; 2007; 66(2-3):228-37. PubMed ID: 17635800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between CD8alphabeta and the TCRalphabeta/CD3-receptor complex.
    Rubin B; Riond J; Leghait J; Gairin JE
    Scand J Immunol; 2006 Sep; 64(3):260-70. PubMed ID: 16918695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T cell antigen receptor alpha and beta chains interact via distinct regions with CD3 chains.
    Manolios N; Kemp O; Li ZG
    Eur J Immunol; 1994 Jan; 24(1):84-92. PubMed ID: 8020575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCR alpha beta chains associate with the plasma membrane independently of CD3 and TCR zeta chains in murine primary T cells.
    Zhang J; Salojin K; Gao JX; Cameron M; Geisler C; Delovitch TL
    J Immunol; 1998 Sep; 161(6):2930-7. PubMed ID: 9743355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full activation of the T cell receptor requires both clustering and conformational changes at CD3.
    Minguet S; Swamy M; Alarcón B; Luescher IF; Schamel WW
    Immunity; 2007 Jan; 26(1):43-54. PubMed ID: 17188005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionally active T cell receptor/CD3 complexes are present at the surface of cloned cytotoxic T cells without fluorescence-immunological detectability.
    Staege MS; Dick T; Reske-Kunz AB
    Cell Immunol; 1996 Jul; 171(1):62-7. PubMed ID: 8660838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes.
    Garcia KC; Scott CA; Brunmark A; Carbone FR; Peterson PA; Wilson IA; Teyton L
    Nature; 1996 Dec; 384(6609):577-81. PubMed ID: 8955273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective interactions between TCR chains and CD3 heterodimers prevent membrane expression of TCR-alpha beta in human T cells.
    Arnaud J; Chenu C; Huchenq A; Gouaillard C; Kuhlmann J; Rubin B
    J Immunol; 1996 Mar; 156(6):2155-62. PubMed ID: 8690904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of extracellular interactions impairs T cell receptor-CD3 complex stability and signaling.
    Kuhns MS; Davis MM
    Immunity; 2007 Mar; 26(3):357-69. PubMed ID: 17368054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conformation- and avidity-based proofreading mechanism for the TCR-CD3 complex.
    Schamel WW; Risueño RM; Minguet S; Ortíz AR; Alarcón B
    Trends Immunol; 2006 Apr; 27(4):176-82. PubMed ID: 16527543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.
    Yasuda T; Bundo K; Hino A; Honda K; Inoue A; Shirakata M; Osawa M; Tamura T; Nariuchi H; Oda H; Yamamoto T; Yamanashi Y
    Int Immunol; 2007 Apr; 19(4):487-95. PubMed ID: 17329234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD3 delta epsilon omega by phorbol 12-myristate 13-acetate.
    Vangsted A; Neisig A; Wallin H; Zeuthen J; Geisler C
    Eur J Immunol; 1993 Jun; 23(6):1351-7. PubMed ID: 8500530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-TCR/CD3 and TCR/CD3 complexes: decamers with differential signalling properties?
    Jacobs H
    Immunol Today; 1997 Dec; 18(12):565-9. PubMed ID: 9425732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell activation. V. Anti-major histocompatibility complex class I antibody-induced activation and clonal abortion in Jurkat T-leukaemic cells.
    Claesson MH; Dissing S; Tscherning T; Geisler C
    Immunology; 1993 Mar; 78(3):444-8. PubMed ID: 8097490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The short length of the extracellular domain of zeta is crucial for T cell antigen receptor function.
    Minguet S; Swamy M; Schamel WW
    Immunol Lett; 2008 Mar; 116(2):195-202. PubMed ID: 18207249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR ligand avidity determines the mode of B-Raf/Raf-1/ERK activation leading to the activation of human CD4+ T cell clone.
    Tsukamoto H; Irie A; Chen YZ; Takeshita K; Kim JR; Nishimura Y
    Eur J Immunol; 2006 Jul; 36(7):1926-37. PubMed ID: 16791876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous involvement of all six predicted antigen binding loops of the T cell receptor in recognition of the MHC/antigenic peptide complex.
    Kasibhatla S; Nalefski EA; Rao A
    J Immunol; 1993 Sep; 151(6):3140-51. PubMed ID: 8376771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
    Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
    Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.